Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double‐blind, placebo‐controlled, clinical trial
出版年份 2021 全文链接
标题
Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double‐blind, placebo‐controlled, clinical trial
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2021-09-14
DOI
10.1111/ijcp.14852
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Naringenin Regulates Doxorubicin-Induced Liver Dysfunction: Impact on Oxidative Stress and Inflammation
- (2020) Adil Farooq Wali et al. Plants-Basel
- Naringenin, a flavanone with antiviral and anti‐inflammatory effects: A promising treatment strategy against COVID ‐19
- (2020) Helda Tutunchi et al. PHYTOTHERAPY RESEARCH
- A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease
- (2020) Fatemeh Naeini et al. Advances in Nutrition
- Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease
- (2019) Carolina M. Perdomo et al. Nutrients
- The Preventive Effects and the Mechanisms of Action of Navel Orange Peel Hydroethanolic Extract, Naringin, and Naringenin in N-Acetyl-p-aminophenol-Induced Liver Injury in Wistar Rats
- (2019) Osama M. Ahmed et al. Oxidative Medicine and Cellular Longevity
- Curcuminoids plus piperine improve nonalcoholic fatty liver disease: A clinical trial
- (2019) Yunes Panahi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo‐controlled, double‐blind clinical trial
- (2019) Makan Cheraghpour et al. PHYTOTHERAPY RESEARCH
- Naringenin attenuates the progression of liver fibrosis via inactivation of hepatic stellate cells and profibrogenic pathways
- (2019) Erika Hernández-Aquino et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Naringenin and its Nano-formulations for Fatty Liver: Cellular Modes of Action and Clinical Perspective
- (2018) Mehdi Zobeiri et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Intervention with citrus flavonoids reverses obesity, and improves metabolic syndrome and atherosclerosis in obese Ldlr-/- mice
- (2018) Amy C. Burke et al. JOURNAL OF LIPID RESEARCH
- Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future
- (2018) Ana Ruth Araújo et al. LIVER INTERNATIONAL
- Beneficial effects of naringenin in liver diseases: Molecular mechanisms
- (2018) Erika Hernández-Aquino et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Naringenin Supplementation to a Chow Diet Enhances Energy Expenditure and Fatty Acid Oxidation, and Reduces Adiposity in Lean, Pair-Fed Ldlr−/− Mice
- (2018) Amy C. Burke et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Protective Effects of Five Structurally Diverse Flavonoid Subgroups against Chronic Alcohol-Induced Hepatic Damage in a Mouse Model
- (2018) Liang Zhao et al. Nutrients
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
- (2017) Chris Estes et al. HEPATOLOGY
- Naringenin prevents experimental liver fibrosis by blocking TGFβ-Smad3 and JNK-Smad3 pathways
- (2017) Erika Hernández-Aquino et al. WORLD JOURNAL OF GASTROENTEROLOGY
- How to Translate Time? The Temporal Aspect of Human and Rodent Biology
- (2017) Denes V. Agoston Frontiers in Neurology
- Apigenin and naringenin regulate glucose and lipid metabolism, and ameliorate vascular dysfunction in type 2 diabetic rats
- (2016) Bei Ren et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Errors in meta-analysis on prevalence of nonalcoholic fatty liver disease
- (2016) Michael Roerecke et al. HEPATOLOGY
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Non-alcoholic Fatty Liver Disease: Beneficial Effects of Flavonoids
- (2016) Masoumeh Akhlaghi PHYTOTHERAPY RESEARCH
- Gut–liver axis, nutrition, and non-alcoholic fatty liver disease
- (2015) Irina A. Kirpich et al. CLINICAL BIOCHEMISTRY
- Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial
- (2015) Shihui Chen et al. DIGESTIVE AND LIVER DISEASE
- Naringenin Prevents Obesity, Hepatic Steatosis, and Glucose Intolerance in Male Mice Independent of Fibroblast Growth Factor 21
- (2015) Julia M. Assini et al. ENDOCRINOLOGY
- Nonalcoholic fatty liver disease - current status and future directions
- (2015) Münevver Demir et al. Journal of Digestive Diseases
- Citrus flavonoid, naringenin, increases locomotor activity and reduces diacylglycerol accumulation in skeletal muscle of obese ovariectomized mice
- (2015) Jia-Yu Ke et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Antioxidant and Hepatoprotective Effects of Naringenin and Its β-Cyclodextrin Formulation in Mice Intoxicated with Carbon Tetrachloride: A Comparative Study
- (2014) Anca Hermenean et al. JOURNAL OF MEDICINAL FOOD
- Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
- (2013) Howard C. Masuoka et al. Annals of the New York Academy of Sciences
- Therapeutic approaches to non-alcoholic fatty liver disease: past achievements and future challenges
- (2013) Jia Xiao et al. Hepatobiliary & Pancreatic Diseases International
- Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?
- (2012) Y. Yilmaz ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Anti-inflammatory role of naringenin in rats with ethanol induced liver injury
- (2012) Jayachitra Jayaraman et al. TOXICOLOGY MECHANISMS AND METHODS
- Protective Effect of Naringenin Against Lead-Induced Oxidative Stress in Rats
- (2011) Jicang Wang et al. BIOLOGICAL TRACE ELEMENT RESEARCH
- Dietary naringenin increases hepatic peroxisome proliferators–activated receptor α protein expression and decreases plasma triglyceride and adiposity in rats
- (2010) Kae Won Cho et al. EUROPEAN JOURNAL OF NUTRITION
- Pathogenesis of non-alcoholic fatty liver disease
- (2009) J. K. Dowman et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor
- (2008) Emma M. Allister et al. JOURNAL OF LIPID RESEARCH
- Naringenin-Loaded Nanoparticles Improve the Physicochemical Properties and the Hepatoprotective Effects of Naringenin in Orally-Administered Rats with CCl4-Induced Acute Liver Failure
- (2008) Feng-Lin Yen et al. PHARMACEUTICAL RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started